Loading...
Loading...
India's apixaban imports from MALTA total $5.6K across 11 shipments from 1 foreign suppliers. TEVA PHARMACEUTICAL INDUSTRIES LTD leads with $5.6K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include WATSON PHARMA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for apixaban — a concentrated sourcing relationship with select suppliers from MALTA.

TEVA PHARMACEUTICAL INDUSTRIES LTD is the leading Apixaban supplier from MALTA to India, with import value of $5.6K across 11 shipments. The top 5 suppliers — TEVA PHARMACEUTICAL INDUSTRIES LTD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $5.6K | 11 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | WATSON PHARMA PRIVATE LIMITED | $5.6K | 11 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Apixaban suppliers from MALTA to India include TEVA PHARMACEUTICAL INDUSTRIES LTD. The leading supplier is TEVA PHARMACEUTICAL INDUSTRIES LTD with import value of $5.6K USD across 11 shipments. India imported Apixaban worth $5.6K USD from MALTA in total across 11 shipments.
India imported Apixaban worth $5.6K USD from MALTA across 11 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Apixaban sourced from MALTA include WATSON PHARMA PRIVATE LIMITED. The largest buyer is WATSON PHARMA PRIVATE LIMITED with $5.6K in imports across 11 shipments.
The total value of Apixaban imports from MALTA to India is $5.6K USD, across 11 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists